Skip to main content

Checking In On Best And Worst Performers From 2011

By: ETFdb
As 2012 draws to a close, we’ve been recapping some of the best and worst ETF performers over the past year. Today, we’re taking a look back at the biggest winners and losers of the previous year–2011– to see how they followed up their impressive (or depressing) years in 2012. Many of the asset classes that surged in 2011 posted another stellar year in 2012, and many of those that struggled mightily in 2011 continued their freefall in 2012. Of course, there are some that dramatically reversed course in 2012. Below, we highlight the ETFs profiled last year in our 10 Equity ETFs That Surged In 2011 and 10 Worst ETF Performers Of 2011 with an update on the 2012 performance [for more ETF ideas, sign up for the free ETFdb newsletter]: [Download 101 ETF Lessons Every Financial Advisor Should Learn]. 1. Dow Jones US Pharmaceuticals (IHE): +14.3% YTD “Pharmaceutical companies have surged higher [...] Click here to read the original article on ETFdb.com. Related Posts: 10 Equity ETFs That Surged In 2011 (And Might Do The Same In 2012) Ten Worst ETF Performers Of 2011 Ten Unexpected Observations On YTD ETF Returns Seven Best ETF Performers Of Q1 (And Five Of The Worst) 10 Worst-Performing ETFs In 2012
As 2012 draws to a close, we’ve been recapping some of the best and worst ETF performers over the past year. Today, we’re taking a look back at the biggest winners and losers of the previous year–2011– to see how they followed up their impressive (or depressing) years in 2012.  Many of the asset classes that surged in 2011 posted another stellar year in 2012, and many of those that struggled mightily in 2011 continued their freefall in 2012. Of course, there are some that dramatically reversed course in 2012. Below, we highlight the ETFs profiled last year in our 10 Equity ETFs That Surged In 2011 and 10 Worst ETF Performers Of 2011 with an update on the 2012 performance [for more ETF ideas, sign up for the free ETFdb newsletter]: [Download 101 ETF Lessons Every Financial Advisor Should Learn].  1. Dow Jones US Pharmaceuticals (IHE): +14.3% YTD “Pharmaceutical companies have surged higher [...]

Click here to read the original article on ETFdb.com.

Related Posts:

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.